Market News
Recent Developments
New product launches
- Medtronic plc, a U.S.-based medical device, services, and solutions company, announced the launch of all-in-one, disposable Simplera, continuous glucose monitor (CGM), featuring a simple, two-step insertion process, and no-fingerstick sensor in Europe as it received Conformité Européenne (CE) Mark approval mark, on September 21, 2023
- Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems, announced the U.S Food and Drug Administration (FDA) approval on February 2022, for next-generation Eversense E3 CGM System. It is indicated to continually measuring glucose levels for up to 6 months in persons with diabetes age 18 and older. The system is indicated for use to replace finger stick blood glucose testing devices.
- In July 2021, Terumo Corporation, a Japan-based global medical technology company, announced the launch of Dexcom G6, the device is a small, wearable sensor, and transmitter to measure and automatically send glucose values wirelessly to a smart device.
Acquisitions and partnerships
- Senseonics Holdings, Inc.: In August 2022, Senseonics Holdings, Inc., a U.S.-based global medical technology company, announced a strategic partnership with Ascensia Diabetes Care (Ascensia), a global diabetes care company. Through this partnership, Ascensia became the exclusive worldwide distributor of Senseonics Holdings, Inc.’s Eversense CGM system.
- Astellas Pharma Inc.: On March 28, 2023, Astellas Pharma Inc., a Japan-based global pharmaceuticals company, announced an partnership agreement with Roche Diabetes Care Japan Co., Ltd, a global pharmaceutical and medical technology company. This agreement is to develop and commercialize integrated diabetes self-management solution with BlueStar, India based electronic manufacturing company
U.S.: 
U.K. : 
India : 
